Zomedica Corp.Long
ZOM reaching denouement in symmetrical triangle
ZOM is about to reach the endpoint of it's symmetrical triangle. ZOM has been in the news a lot recently with the Carole Baskin mention and it also has a heavily patented technology coming out at the end of March. This stock has a great leadership team as well. Do you own do dill but I think this one is going up! Price target is $2.50.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.